In 5xFAD mice and other transgenic models of Alzheimer’s disease, overexpression of APP is accompanied by physiological and structural changes in the hippocampus, leading to the deterioration of cognitive abilities and decreased synaptic integrity [80, 81]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.